About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
FDMT
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- 4D Molecular says its wet AMD therapy cuts Eylea burden
- 4D Molecular Therapeutics GAAP EPS of -$0.79 misses by $0.04, revenue of $0.5M misses by $3.17M
- 4D Molecular up 11% on early-stage data for cystic fibrosis lung disease candidate
- 4D Molecular Therapeutics GAAP EPS of -$0.87, revenue of $0.16M
- 4D Molecular Therapeutics jumps as Jefferies starts with buy rating, $22 PT
- 4D Molecular Therapeutics GAAP EPS of -$0.82 misses by $0.10, revenue of $1.22M beats by $0.46M
- 4D Molecular doses first patient in phase 1/2 trial of 4D-710 for treating cystic fibrosis
- 4D Molecular Therapeutics GAAP EPS of -$2.57, revenue of $18.03M
- 4D Molecular Therapeutics reports phase 1/2 trial interim data of 4D-310 in Fabry disease
- 4D Molecular begins dosing in phase 1/2 trial of gene therapy for eye disorder
- 4D Molecular Therapeutics EPS beats by $0.01
- Ocugen among top healthcare gainers this week; Alzheimer’s setback hurts Cortexyme
- 4D Molecular Therapeutics prices upsized 4.75M stock offering at $25
- 4D Molecular Therapeutics down 5% after hours following 4.5M-share equity offering
- 4D Molecular shows proof-of-concept for Fabry disease candidate with early-stage data
- 4D Molecular up more than 10% as volume is more than 3x daily average
- 4D Molecular's 4D-125 shows promising action in mid-stage inherited retinal dystrophy study
- FDA clears 4D Molecular's IND application for 4D-150 in wet AMD
- FDA clears 4D Molecular's 4D-710 application for cystic fibrosis
- Atea Pharma, Evolent among weekly healthcare gainers; Omeros, Novavax trail
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| November 10, 2021 | -0.82 / -0.805 | 1.37M / 175K | |
| September 1, 2021 | - / -0.68 | - / 587.5K | |
| August 12, 2021 | -0.28 / -0.68 | 14.58M / 587.5K | |
| May 13, 2021 | -0.53 / -0.83 | 2M / 562.5K | |
| March 3, 2021 | -1.02 / -0.66 | -977K / - | |
| December 2, 2020 | -0.4 / - | 7.42M / - |
Beat! |
| November 17, 2020 | -3.07 / - | 2.03M / - |
Beat! |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 | 15.86 | 16.14 |
16.66
|
15.74
|
82.58K | -3.29% | ||||
| Mar 22 | 16.40 | 15.62 |
16.59
|
15.60
|
116.16K | 4.59% | ||||
| Mar 21 | 15.68 | 16.01 |
16.43
|
15.35
|
125.83K | -3.27% | ||||
| Mar 18 | 16.21 | 15.46 |
16.73
|
15.46
|
458.28K | 2.47% | ||||
| Mar 17 | 15.82 | 15.00 |
15.85
|
14.59
|
158.34K | 5.47% | ||||
| Mar 16 | 15.00 | 13.90 |
15.00
|
13.90
|
205.88K | 6.61% | ||||
| Mar 15 | 14.07 | 14.00 |
14.23
|
13.28
|
152.21K | 1.59% | ||||
| Mar 14 | 13.85 | 15.00 |
15.00
|
13.68
|
380.78K | -8.34% | ||||
| Mar 11 | 15.11 | 15.59 |
15.81
|
14.86
|
292.92K | -1.11% | ||||
| Mar 10 | 15.28 | 14.93 |
15.39
|
14.54
|
132.60K | 1.39% | ||||
| Mar 9 | 15.07 | 14.04 |
15.35
|
13.81
|
219.73K | 10.97% | ||||
| Mar 8 | 13.58 | 13.37 |
14.26
|
13.05
|
127.85K | 0.22% | ||||
| Mar 7 | 13.55 | 13.40 |
13.98
|
13.26
|
132.06K | 2.96% | ||||
| Mar 4 | 13.16 | 13.36 |
13.73
|
12.84
|
745.87K | -1.28% | ||||
| Mar 3 | 13.33 | 13.64 |
13.82
|
12.98
|
202.97K | -2.27% | ||||
| Mar 2 | 13.64 | 13.75 |
14.04
|
13.36
|
146.04K | 0.15% | ||||
| Mar 1 | 13.62 | 13.75 |
14.00
|
13.35
|
144.28K | -0.58% | ||||
| Feb 28 | 13.70 | 14.39 |
14.58
|
13.35
|
204.32K | -4.13% | ||||
| Feb 25 | 14.29 | 14.90 |
15.05
|
13.68
|
165.64K | -3.38% | ||||
| Feb 24 | 14.79 | 13.15 |
14.90
|
12.99
|
251.63K | 8.91% | ||||